More articles from Cardiovascular

You have access
Rosuvastatin inhibits the apoptosis of platelet-derived growth factor-stimulated vascular smooth muscle cells by inhibiting p38 via autophagy
Jun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon Myung

Journal of Pharmacology and Experimental Therapeutics April 12, 2021, JPET-AR-2021-000539; DOI: https://doi.org/10.1124/jpet.121.000539
Open Access
An Integrative Approach for Improved Assessment of Cardiovascular Safety Data
Mikael Wallman, Stefan Scheuerer, Eric Martel, Nicolas Pairet, Mats Jirstrand and Johan Gabrielsson

Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 218-231; DOI: https://doi.org/10.1124/jpet.120.000348
You have access
Inhibition of G6PD activity attenuates right ventricle pressure and hypertrophy elicited by VEGFR inhibitor + hypoxia
Atsushi Kitagawa, Christina Jacob, Allan Jordan, Ian Waddell, Ivan F Mcmurtry and Sachin A Gupte

Journal of Pharmacology and Experimental Therapeutics March 23, 2021, JPET-AR-2020-000166; DOI: https://doi.org/10.1124/jpet.120.000166
You have access
Acetate, a Short-Chain Fatty Acid, Acutely Lowers Heart Rate and Cardiac Contractility Along with Blood Pressure
Brian G. Poll, Jiaojiao Xu, Seungho Jun, Jason Sanchez, Nathan A. Zaidman, Xiaojun He, Laeben Lester, Dan E. Berkowitz, Nazareno Paolocci, Wei Dong Gao and Jennifer L. Pluznick

Journal of Pharmacology and Experimental Therapeutics April 2021, 377 (1) 39-50; DOI: https://doi.org/10.1124/jpet.120.000187
You have access
Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng

Journal of Pharmacology and Experimental Therapeutics March 15, 2021, JPET-AR-2020-000361; DOI: https://doi.org/10.1124/jpet.120.000361
You have access
Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II-induced atherosclerosis, abdominal aortic aneurysms, and hypertension
Yasir Alsiraj, Sean Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa Cassis

Journal of Pharmacology and Experimental Therapeutics March 11, 2021, JPET-AR-2021-000525; DOI: https://doi.org/10.1124/jpet.121.000525
You have access
COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels
Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang and Shetuan Zhang

Journal of Pharmacology and Experimental Therapeutics March 5, 2021, JPET-AR-2020-000484; DOI: https://doi.org/10.1124/jpet.120.000484
You have access
β₃-Adrenergic Receptor Agonist Prevents Diastolic Dysfunction in an Angiotensin II–Induced Cardiomyopathy Mouse Model
Masataka Kamiya, Kuniya Asai, Yasuhiro Maejima, Akihiro Shirakabe, Koji Murai, Satsuki Noma, Hidenori Komiyama, Naoki Sato, Kyoichi Mizuno and Wataru Shimizu

Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 473-481; DOI: https://doi.org/10.1124/jpet.120.000140
You have access
A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution
Mathieu Panel, Abdelhakim Ahmed-Belkacem, Isaac Ruiz, Jean-François Guichou, Jean-Michel Pawlotsky, Bijan Ghaleh and Didier Morin

Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 348-357; DOI: https://doi.org/10.1124/jpet.120.000359
You have access
Predictors of Early or Delayed Diastolic Dysfunction After Anthracycline-Based or Nonanthracycline Chemotherapy: A Pharmacological Appraisal
Giorgio Minotti, Pierantonio Menna, Massimiliano Camilli, Emanuela Salvatorelli and Giorgio Reggiardo

Journal of Pharmacology and Experimental Therapeutics February 2021, 376 (2) 231-239; DOI: https://doi.org/10.1124/jpet.120.000323

Main menu

User menu

Search

More articles from Cardiovascular

Pages

Navigate

More Information

ASPET's Other Journals